Unknown

Dataset Information

0

HLA-DR genetic polymorphisms and hepatitis B virus mutations affect the risk of hepatocellular carcinoma in Han Chinese population.


ABSTRACT:

Background

Human leucocyte antigen (HLA)-DR plays a crucial role in the immune response against hepatitis B virus (HBV). We aimed to investigate the associations of HLA-DR single nucleotide polymorphisms (SNPs) with the generation of hepatocellular carcinoma (HCC)-related HBV mutations. The effects of HLA-DR SNPs and their interactions with HBV mutations on HCC risks were also determined.

Methods

Five HLA-DR SNPs (rs3135363, rs9268644, rs35445101, rs24755213, and rs984778) were genotyped in 792 healthy controls, 586 chronic hepatitis B (CHB) patients, 536 liver cirrhosis (LC) patients, and 1500 HCC patients using quantitative PCR. Sanger sequencing was used to identify the HBV mutations. Logistic regression model was performed to evaluate the association of HLA-DR SNPs with HCC risk and the frequencies of HCC-related HBV mutations.

Results

The variant genotypes at rs3135363, rs9268644, rs35445101, rs24755213, and rs984778 were associated with decreased HCC risks. In genotype C HBV-infected subjects, variant genotypes of these SNPs were associated with decreased frequencies of HCC-related HBV mutations such as C1653T, T1674C/G, G1719T, T1753A/C, A1762T/G1764A, A1846T, G1896A, G1899A, and preS deletion. AG genotype at rs3135363, CA genotype at rs9268644, and AG genotype at rs24755213 reduced the generation of T1753A/C and G1896A in genotype B HBV-infected subjects, respectively. In addition, the interactions of rs3135363, rs9268644, rs24755213 with C1653T, T1753A/C, A1846T, and G1896A decreased the risks of HCC.

Conclusions

HLA-DR genetic polymorphisms might predispose the host to immunoselection of HCC-related HBV mutations and affect the HCC risks possibly through interacting with HBV mutations.

SUBMITTER: Zhao Y 

PROVIDER: S-EPMC10691135 | biostudies-literature | 2023 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

HLA-DR genetic polymorphisms and hepatitis B virus mutations affect the risk of hepatocellular carcinoma in Han Chinese population.

Zhao Yubao Y   Chen Kun K   Yang Hui H   Zhang Feng F   Ding Lu L   Liu Yan Y   Zhang Le L   Zhang Yuchen Y   Wang Huiliang H   Deng Yang Y  

Virology journal 20231130 1


<h4>Background</h4>Human leucocyte antigen (HLA)-DR plays a crucial role in the immune response against hepatitis B virus (HBV). We aimed to investigate the associations of HLA-DR single nucleotide polymorphisms (SNPs) with the generation of hepatocellular carcinoma (HCC)-related HBV mutations. The effects of HLA-DR SNPs and their interactions with HBV mutations on HCC risks were also determined.<h4>Methods</h4>Five HLA-DR SNPs (rs3135363, rs9268644, rs35445101, rs24755213, and rs984778) were ge  ...[more]

Similar Datasets

| S-EPMC5348366 | biostudies-literature
| S-EPMC6965258 | biostudies-literature
| S-EPMC9706882 | biostudies-literature
| S-EPMC5662339 | biostudies-literature
| S-EPMC3854376 | biostudies-literature
| S-EPMC3807892 | biostudies-literature
| S-EPMC5369979 | biostudies-literature
| S-EPMC3386326 | biostudies-literature
| S-EPMC10079871 | biostudies-literature
| S-EPMC6087028 | biostudies-literature